Rovis Gel

NDC:

72934-1532-02

SKNV Code:

171082
Formulation:
NIACINAMIDE 4% / BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1%
Common Usage:
Rosacea
Packaging:
30 ML AIRLESS PUMP
Rovis Gel 30ml airless pump – Brimonidine Tartrate 0.25% Ivermectin 1% Metronidazole 1% Niacinamide 4% compounded by SKNV Pharmacy
Previously known as Dazaveidaoxia Gel
Rovis Gel combines brimonidine tartrate 0.25%, ivermectin 1%, metronidazole 1% and niacinamide 4% with potassium azeloyl diglycinate. Brimonidine helps reduce the look of persistent facial redness, ivermectin and metronidazole target bumps and inflammation, and niacinamide supports the skin barrier. This provider-prescribed gel is designed for patients with rosacea redness and breakouts. It is formulated without titanium dioxide, propylene glycol and methylparaben.

Quality Without Compromise

Medications without potential allergens or irritants for certain patients, as determined by your provider*

How to Send a 

Rovis Gel

Prescription Through Your EMR

1. Select ‘SKNV Pharmacy’ in the prescribing section of your EMR.
2. Enter '
Rovis Gel
' in your EMR.

3. Enter the SKNV medication name found in column 1. 

All medications are already loaded in your EMR.

You can locate SKNV in your EMR by one of the following:

  • Name – SKNV Pharmacy
  • NCPDP: 5754634
  • NABP: 1726341
  • City: Deerfield Beach
  • ZIP code:  33442
4. Make sure the patient’s cell phone is the primary contact in your EMR, then submit the prescription.

Let your patient know they will receive a text message to pay for the prescription.

Once payment is made and the RX is dispensed, the patient will receive a text message with the tracking information.

Discover the full range of SKNV medications available for your patients. Explore our complete catalog to find the right solution for your practice and patient needs.

These medications are made by SKNV, an FDA-registered 503B outsourcing facility that specializes in customized medications to meet unique patient needs. The prescribing doctor will determine if the medication makes a clinical difference for the individual patient. The FDA does not review medications made in an outsourcing facility for any particular indication, safety or efficacy. SKNV makes no claims its customized medications are safer or more efficacious than a commercially available drug. Any references to “common usages” should not be interpreted as recommendations or claims regarding the clinical indication of any medication.